Chan ATC, Leung SF, Ngan RKC, Teo PML, Lau WH, Kwan WH, Hui EP, Cheung FY, Yeo W, Yiu HH, Yu KH, Chiu KW, Chan DT, Mok TSK, Yuen KT, Mo FKF, Lai MMP, Ma BBY, Johnson PJ, Zee BCY. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005;97:536-9.

Chan KC, Yeung SW, Lui WB, Rainer TH, Lo YM. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem. 2005 Apr;51(4):781-4.

Chen GG, Sin FL, Leung BC, Ng HK, Poon WS. Differential role of hydrogen peroxide and staurosporine in induction of cell death in glioblastoma cells lacking DNA-dependent protein kinase. Apoptosis. 2005;10(1):185-92.

Chen GG, Sin FL, Leung BC, Ng HK, Poon WS. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death. J Cell Physiol. 2005;203(1):127-32.

Liu Z, Ng EK, Liang NC, Deng YF, Leung BC, Chen GG. Cell death induced by Pteris semipinnata L. is associated with p53 and oxidant stress in gastric cancer cells. FEBS Lett. 2005;579(6):1477-87.

Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem. 2005;51(2):328-35.

Sung FL, Poon TC, Hui EP, Ma BB, Liong E, To KF, Huang DP, Chan AT. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo. 2005;19(1):237-45.

Wong SC, Chan JK, Lee KC, Lo ES, Tsang DN. Development of a quantitative assay for SARS coronavirus and correlation of GAPDH mRNA with SARS coronavirus in clinical specimens. J Clin Pathol. 2005;58(3):276-80.

Bai AH, Tong JH, To KF, Chan MW, Man EP, Lo KW, Lee JF, Sung JJ, Leung WK. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer. 2004;112(5):846-53.

Chan ATC, Ma BBY, Lo YMD, Teo P, Kwan WH, Hui EP, Mok T, Leung SF, Kam M, Chan LS, Chiu KW, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Zee B. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma - therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 2004;22:3053-60.

Chan AT, Tao Q, Robertson KD, Flinn IW, Mann RB, Klencke B, Kwan WH, Leung TW, Johnson PJ, Ambinder RF. Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. J Clin Oncol. 2004;22(8):1373-81.

Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut. 2004;53(10):1494-8.

Chen GG, Lai PB, Ho RL, Chan PK, Xu H, Wong J, Lau WY. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus. J Med Virol. 2004;73(2):187-94.

Chen GG, Liang NC, Lee JF, Chan UP, Wang SH, Leung BC, Leung KL. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis. 2004;9(5):619-27.

Chen GG, Liu ZM, Vlantis AC, Tse GM, Leung BC, van Hasselt CA. Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J Cell Biochem. 2004;92(6):1246-56.

Cheng AS, Chan HL, Leung WK, To KF, Go MY, Chan JY, Liew CT, Sung JJ. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2. Mod Pathol. 2004;17(10):1169-79.

Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. Int J Oncol 2004;24(4):853-60.

Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int 2004;75(1):71-7.

Chi TY, Chen GG, Lai PB. Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J 2004;10(3):190-200.

Du J, Chen GG, Vlantis AC, Chan PK, Tsang RK, van Hasselt CA. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Cancer Lett 2004;205(1):81-8.

Huang L, Teng XY, Cheng YY, Lee KM, Kumta SM. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone 2004;34(3):393-401.

Huang L, Xu J, Li K, Zheng MH, Kumta SM. Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone. Bone 2004;34(6):971-81.

Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, Friedman SLProstaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol 2004;41(2):251-8.

Leung WK, Bai AH, Chan VY, Yu J, Chan MW, To KF, Wu JR, Chan KK, Fu YG, Chan FK, Sung JJ. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. Gut.2004;53(3):331-8.

Lit LC, Chan KC, Leung SF, Lei KI, Chan LY, Chow KC, Chan AT, Lo YM. Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma. Clin Chem. 2004;50(10):1842-5.

Liu ZM, Chen GG, Ng EK, Leung WK, Sung JJ, Chung SC. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene. 2004;23(2):503-13.

Miao J, Chen GG, Chun SY, Chak EC, Lai PB. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma. Int J Oncol. 2004;25(3):651-9.

Yu KH, Lo YM, Tse GM, Chan KC, Chan AB, Chow KC, Ma TK, Vlantis AC, Leung SF, van Hasselt CA, Johnson PJ, Chan AT. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas. Clin Cancer Res. 2004;10(5):1726-32.

Chan CML, Poon TCW, Pang RTK, Wong NLY, Yu JWS, Wong N, Johnson PJ, Chan ATC. Comparative proteomic analysis of a hepatoblastoma cell line HepG2 and three hepatocellular carcinoma cell lines. Proceedings of 94th Annual Meeting of the American Association for Cancer Research (AACR). Vol 41. 2003.

Chan KCA, Zhang J, Chan ATC, Lei KIK, Leung SF, Chan LYS, Chow KCK, Lo YMD. Molecular characterization of circulating Epstein-Barr virus DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003;63:2028-32.

Chan MH, Chow KM, Chan ATC, Leung CB, Chow KC, Lam CW, Lo YM. Quantitative analysis of pleural fluid cell-free DNA as a novel tool for the classification of pleural effusions. Clin Chem 2003;49:740-5.

Chan S, Lo KW, Hui ABY, To KF and Huang DP. Serial analysis of gene expression in nasopharyngeal carcinoma. J HK College of Radiology Suppl 2003; 6:72.

Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Int J Oncol 2003;23(1):113-9.

Chow LSN, Lo KW, To KF, Dammann R and Huang Dolly P. RASS1A is a candidate tumor suppressor in nasopharyngeal carcinoma. J HK College of Radiology Suppl 2003; 6:89.

de Jesus O, Smith PR, Spender LC, Elgueta Karstegl C, Niller HH, Huang D, Farrell PJ. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 2003;84(Pt 6):1443-50.

Hui ABY, Lo KW, Lau KM, Hui WY, Tsang K and Huang DP. Anti-proliferative effects of resveratrol in EBV positive nasopharyngeal carcinoma cells. J HK Coll Radiol Suppl 2003; 6:98.

Hui EP, Poon TC, Teo PM, Mo F, Zee B, Leung SF, Ho S, Mok TS, Kwan WH, Johnson PJ, Chan AT. A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma. Radiotherapy & Oncology 2003; 69(1):53-62.

Kwong J, Lo KW, To KF, Wong YH and Huang DP. Silencing of Tazarotene-induced gene 1 (TIG1) by promoter hypermethylation in nasopharyngeal carcinoma (NPC). J HK Coll Radiol Suppl 2003; 6:101.

Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer. 2003;98(2):288-91.

Leung SF, Lo YM, Chan AT, To KF, To E, Chan LY, Zee B, Huang DP, Johnson PJ. Disparity of sensitivities in detection of radiation-naive and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2. Clin Cancer Res. 2003;9(9):3431-4.

Ma B, Poon TCW, To KF, Zee B, Mo KF, Chan CML, Ho S, Teo PML, Johnson PJ, Chan ATC. Prognostic significance of tumor angiogenesis, Ki67, P53, Epidermal growth factor receptor and Her2 protein expressions in undifferentiated nasopharyngeal carcinoma - a prospective study. Head and Neck 2003;25:864-72.

Ng EKO, Tsui NB, Lau TK, Leung TN, Chiu RWK, Panesar NS, Lit LC, Chan KW, Lo YMD. mRNA of placental origin is readily detectable in maternal plasma. Proceedings of the National Academy of Sciences (USA) 2003; 100: 4748-4753.

Pang RTK, Poon TCW, Chan CML, Tsao SW, Huang DP, Chan ATC. Comparative proteomic study of an immortalized normal nasopharyngeal epithelial cell line and an Epstein-Barr Virus positive nasopharyngeal cell line using isotope-coded affinity tags and mass spectrometry. Proceedings of 94th Annual Meeting of the American Association for Cancer Research (AACR). Vol 41. 2003.

Poon TCW, Yip TT, Chan ATC, Yip C, Yip V, Mok TSK, Leung TWT, Ho S, Johnson PJ. Comprehensive Proteomic Profiling Identifies Serum Proteomic Signatures for Detection of Hepatocellular Carcinoma and its Subtypes. Clinical Chemistry 2003; 49: 752-760.

To EWH, Chan KCA, Leung SF, Chan LYS, To KF, Chan ATC, Johnson PJ, Lo YMD. Rapid clearance of plasma Epstein-Barr virus DNA following surgical treatment of nasopharyngeal carcinoma. Clinical Cancer Research 2003;9:3254-9.

Vicat JM, Ardila-Osorio H, Khabir A, Brezak MC, Viossat I, Kasprzyk P, Jlidi R, Opolon P, Ooka T, Prevost G, Huang DP, Busson P. Apoptosis and TRAF-1 cleavage in Epstein-Barr virus-positive nasopharyngeal carcinoma cells treated with doxorubicin combined with a farnesyl-transferase inhibitor. Biochem Pharmacol 2003; 65: 423-33.

Wong IHN, Zhang J, Lai PB, Lau WY, Lo YMD. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clinical Cancer Research 2003; 9: 1047-1052.

Wong N, Chan A, Lee SW, Lam E, To KF, Lai PBS, Li XN, Liew CT, Johnson PJ. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. J Hepatology 2003; 38:298-306.

Wong N, Hui A. BY, Fan B, Lo KW, Pang E, Leung SF, Huang DP, Johnson PJ. Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Cancer Genetics Cytogenetics 2003; 140: 124-132.

Yeo W, Chan Paul KS, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S and Johnson PJ. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. Journal of Medical Virology 2003;70:553-6.

Zhong S, Yeo W, Tang M, Wong N and Johnson PJ. Intensive hypermethylation of the CpG island of Ras association domain family 1a (RASSF1A) in HBV-associated hepatocellular carcinomas. Clinical Cancer Research 2003;9:3376-82.

Chan ASC, To KF, Lo KW, Johnson PJ and Huang Dolly. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 2002; 102: 300-03.

Chan ATC, Lo DYM, Zee B, Chan LYS, Ma BBY, Leung SF, Mo F, Lai M, Huang DP and Johnson PJ.
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst. 2002; 94: 1614-19.

Chan ATC, Teo PML, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002;13:1007-1015.

Chan ATC, Teo PML, Ngan RK, Leung TW, Lau WH, Zee B, Leung SF, Cheng FY, Yeo W, Yu HH, Yu KH, Chiu KW, Chan DT, Mok T, Yuen K, Mo F, Lai M, Kwan WH, Choi P, Johnson PJ. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma : progression free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-44.

Chan BCL, To KF, Pang JCS, Chung YF, Lo KW, Tong JHM, Huang Dolly, Lim PK and Chui YL. Generation of monoclonal antibodies against Hong Kong nasopharyngeal carcinoma-associated Epstein-Barr virus latent membrane protein 1 (LMP1). Int J Cancer 2002; 102: 492-98.

Chan JYH, Meng CL, To KF, Leung SF, Chan ATC, Lee KKH, Johnson PJ. Differential expression of the suppressor PML and Ki67 identifies three subtypes of human nasopharyngeal carcinoma. Eur J Cancer 2002;38:1600-06.

Chan KC, Lo YMD. Circulating nucleic acids as a tumor marker. Histol Histopathol 2002; 17: 937-943.

Chan KCA, Lo YMD. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 489-496.

Cheng AS, Chan HL, Leung NW, Liew CT, To KF, Lai PB, Sung JJ. Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment Pharmacol Ther 2002 ;16(2):251-60.

Dong SM, Pang JCS, Hu J, Zhou LF, Ng HK. Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer 2002;98:370-5

Dong ZQ, Pang JCS, Tong CYK, Zhou LF, Ng HK. Clonality of oligoastrocytomas. Hum Pathol 2002;33: 528-35.

Hu J, Jiang C, Ng HK, Pang JCS, Tong CY. Chromosome 14q may harbor multiple tumor suppressor genes in primary glioblastoma multiforme. Chinese Medical Journal (Eng) 2002;115: 1201-4.

Hu J, Pang JCS, Tong CYK, Lau B, Yin XL, Poon WS, Jiang CC, Zhou LF, Ng HK. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours. Br J Cancer 2002;87: 218-24.

Huang Dolly P and Johnson PJ. Guest Editors for 9 review articles in a NPC series titled "Seminars in Nasopharyngeal Cancer". Semin Cancer Biol 2002; 12 (6): 415-505.

Huang Dolly P, To KF and Lo KW. Review: Molecular pathogenesis of nasopharyngeal carcinoma. Epstein-Barr Virus Report 2002; 9: 43-54.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 2002; 8:2595-604.

Johnson PJ, Lo YMD. Plasma nucleic acids in the diagnosis and management of malignant disease. Clinical Chemistry 2002; 48: 1186-1193.

Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, Sepulveda AR. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002; 123: 542-53.

Kwong J, Lo KW, To, KF, Teo PML, Johnson PJ and Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clinical Cancer Research 2002; 8:131-7.

Lee TL, Leung WK, Chan MWY, Ng EKW, Tong JHM, Lo KW, Chung SCS, Sung JJY, To KF. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clinical Cancer Research 2002; 8: 1761-6.

Leung THY, Wong N, Lai PBS, Chan A, To KF, Liew CT, Lau WY, Johnson PJ. Identification of Four Distinct Regions of Allelic Imbalances on Chromosome 1 by the Combined CGH and Microsatellite Analysis on Hepatocellular Carcinoma. Modern Pathology 2002; 15: 1213-20.

Leung WK, Yu J, Chan FKL, To KF, Chan MWY, Ebert MPA, Ng EKW, Chung SCS, Malfertheiner P, Sung JJY. Expression of trefoil peptides (TFF1, TFF2, TFF3) in gastric carcinomas, intestinal metaplasia and non-neoplastic tissues. Journal of Pathology 2002;197: 582-8.

Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H and Liu FF. Tumour targeted gene therapy for nasopharyngeal carcinoma. Cancer Research 2002; 62: 171-8.

Lo KW and Huang DP. Review: Genetic and Epigenetic changes in nasopharyngeal carcinoma. Seminars in Cancer Biology. 2002; 12: 451-63.

Lo KW, Tsang YS, Kwong J, To KF, Teo PML and Huang DP. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. International Journal of Cancer 2002; 98: 651-5.

Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P. A phase I-II study of sequential administration of topotecan and node etoposide in the treatment of patients with small cell lung carcinoma. Cancer 2002;95:1511-9.

Ng EKO, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, Lo ESF, Rainer TH, Johnson PJ, Lo YMD. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clinical Chemistry 2002; 48: 1212-1217.

Poon TCW, Mok TSK, Chan ATC, Chan CML, Leung V, Tsui STH, Leung TWT, Wong HTM, Ho SKW, Johnson PJ. Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein. Clinical Chemistry 2002; 48(7):1021-1027.

Tian XX, Pang JCS, Zheng J, Chen J, To SST, Ng HK. Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length. British Journal of Cancer 2002; 86:1328-32.

To KF, Leung WK, Lee TL, Yu J, Tong JHM, Chan MWY, Ng EKW, Chung SCS, Sung JJY. Promoter hypermethylation of tumor related genes in gastric intestinal metaplasia with or without gastric cancer. Int J Cancer 2002:102:623-8.

Tong JHM, Tsang RKY, Lo KW, Woo JKS, Kwong J, Chan MWY, Chang AR, van Hasselt CA, Huang DP and To KF. Quantiative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clinical Cancer Research 2002; 8: 2612-9.

Tsao SW, Tramoutanis G, Dawson CW, Lo AKF and Huang DP. The significance of LMP1 expression in nasopharyngeal carcinoma. Seminars in Cancer Biology 2002; 12: 473-89.

Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clinical Chemistry 2002; 48: 1647-1653.

Whitney B, Chan ATC., Rickinson AB., Lee S.P., Lin CK., Johnson PJ. Frequency of Epstein-Barr virus-specific CTLs in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients. J Med Virol 2002;67:359-63.

Wong GK, Boet R, Poon WS, Ng HK. Lytic skull metastasis secondary to thyroid carcinoma in an adolescent. Hong Kong Medical Journal 2002;8:149-51.

Wong N, Li L, Tsang K, Lai PBS, To KF, Johnson PJ. Frequent loss of chromosome 3p and hypermethylation of RASSF1A in Cholangiocarcinoma. J Hepatology 2002; 37:633-9.

Yeo W, Mok TS, Tse KK, Kwan WH, Lam KC, Ho WM, Chiu SK, Chan AT, Leung TW, Mo FK, Johnson PJ. Phase II study of docetaxel and epiribicin in Chinese patients with metastatic breast cancer. Anitcancer Drugs 2002;13:655-62.

Yin XL, Hui AB, Liong EC, Ding M, Chang AR, Ng HK. Genetic imbalances in pleomorphic xanthoastrocytoma detected by comparative genomic hybridization and literature review. Cancer Genetics and Cytogenetics 2002;132:14-9.

Yin XL, Hui ABY, Pang JCS, Poon WS, Ng HK. Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization. Cancer Genetics Cytogenetics 2002;134:71-6.

Yin XL, Pang JCS, Ng HK. Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma. Oncogene 2002;21:1461-8.

Yu J, Leung WK, Ebert MPA, Ng EKW, Go MYY, Wang HB, Malfertheiner P, Sung JJY. Increased Expression of Survivin in Gastric Cancer and in First Degree Relatives: Relationship with Cyclooxygenase-2 Expression. Br J Cancer 2002;87: 91-7.

Yu J, Leung WK, Go MYY, To KF, Ng EKW, Ling TKW, Chung SCS, Sung JJY. The relationship of Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002;51:480-4.